Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease

Thrombosis and Haemostasis

Volumn 89, Issue 4, 2003, Pages 681-686

  Miyamoto, Shinzo ^a   Kawano, Hiroaki ^a   Sakamoto, Tomohiro ^a   Soejima, Hirofumi ^a   Kajiwara, Ichiro ^a   Shimomura, Hideki ^a   Kojima, Sunao ^a   Hokamaki, Jun ^a   Sugiyama, Seigo ^a   Hirai, Nobutaka ^a   Yoshimura, Michihiro ^a   Ozaki, Yukio ^b   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Cardiovascular events; Coronary artery disease; Coronary risk factor; Platelet aggregation

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION FUNCTION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HUMAN; INSTRUMENT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBUS;

EID: 0037393558     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613575     Document Type: Article

References (27)

1. Ault KA, Cannon CP, Mitchell J, et al. Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1999; 33: 634-9.
2. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
3. Ries H, Braun G, Brehm G, Hiller E. Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol 1986; 85: 50-6.
4. Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218: 284-94.
5. Satoh K, Ozaki Y, Qi R, et al. Factors that affect the size of platelet aggregates in epinephrine-induced activation: A study using the particle counting method based on light scattering. Thromb Res 1996; 81: 515-523.
6. Eto K, Takeshita S, Ochiai M, Ozaki Y, Sato T, Isshiki T. Platelet aggregation in acute coronary syndromes: Use of a new aggregometer with laser scattering to assess platelet aggregability. Cardiovasc Res 1998; 40: 223-9.
7. Miyamoto S, Ogawa H, Soejima H, et al. Increased rate of formation of small-sized platelet aggregates in patients with acute coronary syndromes. Jpn Circ J 2000; 64: 647-52.
8. Trip DM, Cats MV, Van Capelle LJF, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322: 1549-54.
9. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84: 613-7.
10. Breddin HK, Lippold R, Bittner M, Kirchmaier CM, Krzywanek HJ, Michaelis J. Spontaneous platelet aggregation as a predictive risk factor for vascular occlusion in healthy volunteers? Results of the HAPARG study. Atherosclerosis 1999; 144: 211-9.
11. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982; 66: 562-8.
12. Califf RM, Mark DB, Harrell FE Jr, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol 1988; 11: 20-6.
13. Sakamoto T, Ogawa H, Kawano H, et al. Rapid change of platelet aggregability in acute hyperglycemia detection by a novel laser-light scattering method. Thromb Haemost 2000; 83: 475-9.
14. Miyamoto S, Ogawa H, Soejima H, et al. Formation of platelet aggregates after attacks with coronary spastic angina pectoris. Am J Cardiol 2000; 85: 494-7.
15. Tohgi H, Takahashi H, Watanabe K, Kuki H, Shirasawa Y. Development of large platelet aggregates from small aggregates as determined by laser-light scattering: Effect of aggregant concentration and antiplatelet medication. Thromb Haemost 1996; 75: 838-43.
16. The expert committee. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
17. Shukla SD, Paul A, Klachko DM. Hypersensitivity of diabetic human platelets to platelet activating factor. Thromb Res 1992; 66: 239-46.
18. Davi G, Gresele P, Violi F, et al. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 1997; 96: 69-75.
19. Hawkins R. Smoking, platelets and thrombosis. Nature 1972; 236: 450-2.
20. Kabbani SS, Watkins MW, Ashikaga T, et al. Platelet reactivity characterized prospectively. A determinant of outcome 90 days after percutaneous coronary intervention. Circulation 2001; 104: 181-6.
21. Kajiwara I, Ogawa H, Soejima H, et al. The prognostic value of small-sized platelet aggregates in unstable angina: Detection by a novel laser-light scattering method. Thromb Res 2001; 101: 109-18.
22. Holmes DR Jr, Detre KM, Williams DO, et al. Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry. Circulation 1993; 87: 21-9.
23. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-70.
24. Fuster V, Dyken ML, Vokonas PS, Hennekens C. Aspirin as a therapeutic agent in cardiovascular disease. Circulation 1993; 87: 659-75.
25. Antiplatelet trialists' collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988; 296: 320-31.
26. Yasue H, Ogawa H, Tanaka H, et al. Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Am J Cardiol 1999; 83: 1308-13.
27. Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets: I: Acetylation of a particulate fraction protein. J Clin Invest 1975; 56: 624-9.